101 related articles for article (PubMed ID: 18162776)
1. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.
Atkins KA; Arronte N; Darus CJ; Rice LW
Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776
[TBL] [Abstract][Full Text] [Related]
2. Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma.
Zhang Q; Ubago J; Li L; Guo H; Liu Y; Qiang W; Kim JJ; Kong B; Wei JJ
Cancer; 2014 Oct; 120(20):3165-77. PubMed ID: 24986214
[TBL] [Abstract][Full Text] [Related]
3. Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.
Pang SJ; Li CC; Shen Y; Liu YZ; Shi YQ; Liu YX
Int J Clin Exp Pathol; 2015; 8(5):4418-26. PubMed ID: 26191133
[TBL] [Abstract][Full Text] [Related]
4. FOXO3a deregulation in uterine smooth muscle tumors.
de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
[TBL] [Abstract][Full Text] [Related]
5. Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis.
Momeni-Boroujeni A; Yousefi E; Balakrishnan R; Riviere S; Kertowidjojo E; Hensley ML; Ladanyi M; Ellenson LH; Chiang S
Mod Pathol; 2023 Apr; 36(4):100084. PubMed ID: 36788080
[TBL] [Abstract][Full Text] [Related]
6. Uterine Leiomyosarcoma Associated With Leiomyoma With Bizarre Nuclei: Histology and Genomic Analysis of 2 Cases.
Fischer JV; Mejia-Bautista M; Vadasz B; Yin P; Bulun S; Tanner EJ; Lu X; Wei JJ
Int J Gynecol Pathol; 2022 Nov; 41(6):552-565. PubMed ID: 35093974
[TBL] [Abstract][Full Text] [Related]
7. Uterine Leiomyosarcoma With Osteoclast-like Giant Cells: Report of 2 Cases and Review of Literature.
Chen Z; Ji J; Yung E; Martin SE; Walia S
Int J Gynecol Pathol; 2024 Mar; 43(2):182-189. PubMed ID: 37406452
[TBL] [Abstract][Full Text] [Related]
8. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.
Beck AH; Lee CH; Witten DM; Gleason BC; Edris B; Espinosa I; Zhu S; Li R; Montgomery KD; Marinelli RJ; Tibshirani R; Hastie T; Jablons DM; Rubin BP; Fletcher CD; West RB; van de Rijn M
Oncogene; 2010 Feb; 29(6):845-54. PubMed ID: 19901961
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes.
Hemming ML; Fan C; Raut CP; Demetri GD; Armstrong SA; Sicinska E; George S
Mol Cancer Res; 2020 Sep; 18(9):1302-1314. PubMed ID: 32518213
[TBL] [Abstract][Full Text] [Related]
10. Uterine Inflammatory Myofibroblastic Tumors: p16 as a Surrogate for CDKN2A Deletion and Predictor of Aggressive Behavior.
Devins KM; Ordulu Z; Mendoza RP; Croce S; Haridas R; Wanjari P; Pinto A; Oliva E; Bennett JA
Am J Surg Pathol; 2024 Apr; ():. PubMed ID: 38630911
[TBL] [Abstract][Full Text] [Related]
11. Uterine smooth muscle tumor of uncertain malignant potential (STUMP) ABOUT a CASE.
Amal C; Fadwa A; Aicha G; Boufetal H; Mahdaoui S; Samouh N
Int J Surg Case Rep; 2024 Apr; 117():109556. PubMed ID: 38518473
[TBL] [Abstract][Full Text] [Related]
12. Uterine Smooth Muscle Tumors: An Overview.
Pinto A
Adv Anat Pathol; 2024 Apr; ():. PubMed ID: 38647238
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors.
Chen L; Yang B
Int J Gynecol Pathol; 2008 Jul; 27(3):326-32. PubMed ID: 18580309
[TBL] [Abstract][Full Text] [Related]
14. Predictors of adverse outcome in uterine smooth muscle tumours of uncertain malignant potential (STUMP): a clinicopathological analysis of 22 cases with a proposal for the inclusion of additional histological parameters.
Gupta M; Laury AL; Nucci MR; Quade BJ
Histopathology; 2018 Aug; 73(2):284-298. PubMed ID: 29537683
[TBL] [Abstract][Full Text] [Related]
15. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
Bell SW; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
[TBL] [Abstract][Full Text] [Related]
16. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
Ip PP; Cheung AN; Clement PB
Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
[TBL] [Abstract][Full Text] [Related]
17. A clinicopathologic review and obstetric outcome of uterine smooth muscle tumor of uncertain malignant potential (STUMP) in a single institution.
Ha HI; Choi MC; Heo JH; Kim KA; Jung SG; Park H; Joo WD; Song SH; Kim TH; Lee C
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():1-5. PubMed ID: 29902779
[TBL] [Abstract][Full Text] [Related]
18. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
[TBL] [Abstract][Full Text] [Related]
19. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
20. Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients.
Prayson RA; Goldblum JR; Hart WR
Am J Surg Pathol; 1997 Apr; 21(4):383-91. PubMed ID: 9130984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
